Study of the Association Between Presbycusis With the Incidence of Frailty
1 other identifier
observational
300
1 country
1
Brief Summary
The objective of the project is to establish the association between presbycusis and the incidence of frailty in humans in order to establish hearing loss with age as another index for the diagnosis of frailty; As well as studying the effect of exposure to polyphenols in the diet on presbycusis and frailty. Human study: volunteers between 60 and 99 years old, men and women during a period of 6 months, questions and answers, audiometries, study of fragility, analysis of antioxidants in blood, and samples of urine will be measured Total polyphenols and oxidant capacity.
Trial Health
Trial Health Score
Automated assessment based on enrollment pace, timeline, and geographic reach
participants targeted
Target at P75+ for all trials
Started Nov 2020
1 active site
Health score is calculated from publicly available data and should be used for screening purposes only.
Trial Relationships
Click on a node to explore related trials.
Study Timeline
Key milestones and dates
First Submitted
Initial submission to the registry
March 9, 2020
CompletedFirst Posted
Study publicly available on registry
April 24, 2020
CompletedStudy Start
First participant enrolled
November 2, 2020
CompletedPrimary Completion
Last participant's last visit for primary outcome
November 1, 2022
CompletedStudy Completion
Last participant's last visit for all outcomes
November 1, 2022
CompletedOctober 22, 2021
October 1, 2021
2 years
March 9, 2020
October 21, 2021
Conditions
Outcome Measures
Primary Outcomes (2)
Auditory function
study by pure tone audiometry, calculating an average of the thresholds of hearing at 0.5, 1, 2 and 4 kilohertz classifying according to their hearing thresholds to the participants in: normal hearing ≤ 25decibel, slight hearing loss = 26-40 decibel; Y moderate-greater hearing loss\> 40 decibel (according to the World Health Organization).
6 months
Frailty
Fragility will be determined at the beginning and at the end of the study period using the 5 Fried indexes: weakness, low speed, low physical activity, exhaustion and weight loss. Participants with 3 or more criteria are classified as fragile, with 1-2 criteria as pre-fragile, and those without any criteria are not considered fragile. Thus, individuals will be classified in the analyzes as non-fragile, pre-fragile and fragile.
6 months
Secondary Outcomes (3)
Determination of total polyphenols in urine
measured twice in each volunteer, at the beginning and end of the study period (6 months)
Blood analysis,
It will be performed at the beginning and at end of the study period (6 months)
Microbiota
It will be performed at the beginning and at end of the study period (6 months)
Eligibility Criteria
People who meet the inclusion and exclusion criteria and who attend the ENT or geriatrics clinic
You may qualify if:
- Age
You may not qualify if:
- Disease of the hearing system
- Serious illness (e.g. tumor)
- Dementia
- Total dependence
Contact the study team to confirm eligibility.
Sponsors & Collaborators
Study Sites (1)
Hospital Universitario de Getafe
Getafe, Madrid, 28905, Spain
MeSH Terms
Conditions
Condition Hierarchy (Ancestors)
Study Officials
- PRINCIPAL INVESTIGATOR
Carolina S Rodríguez
Universidad Europea de Madrid
Central Study Contacts
Study Design
- Study Type
- observational
- Observational Model
- COHORT
- Time Perspective
- PROSPECTIVE
- Target Duration
- 6 Months
- Sponsor Type
- OTHER
- Responsible Party
- PRINCIPAL INVESTIGATOR
- PI Title
- Principal Investigator
Study Record Dates
First Submitted
March 9, 2020
First Posted
April 24, 2020
Study Start
November 2, 2020
Primary Completion
November 1, 2022
Study Completion
November 1, 2022
Last Updated
October 22, 2021
Record last verified: 2021-10